Whole brain radiotherapy in management of non-small-cell lung carcinoma associated leptomeningeal carcinomatosis: evaluation of prognostic factors

Journal of Neuro-Oncology

Volumn 129, Issue 2, 2016, Pages 329-335

  Ozdemir, Yurday ^a   Yildirim, Berna Akkus ^a   Topkan, Erkan ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Leptomeningeal carcinomatosis; Non small cell lung cancer; Prognostic factors; Whole brain radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN METASTASIS; CANCER GROWTH; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CARCINOMATOUS MENINGITIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; WHOLE BRAIN RADIOTHERAPY; ADOLESCENT; BRAIN; BRAIN TUMOR; COMPLICATION; LUNG TUMOR; MIDDLE AGED; PROCEDURES; PROGNOSIS; SKULL IRRADIATION; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CRANIAL IRRADIATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MENINGEAL CARCINOMATOSIS; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84974824227     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-016-2179-9     Document Type: Article

References (28)

1. Sorensen JB, Hansen HH, Hansen M, Dombernowsky P (1988) Brain metastases in adenocarcinoma of the lung: frequency, risk groups, and prognosis. J Clin Oncol 6(9):1474–1480
2. Kocher M, Wittig A, Piroth MD, Treuer H, Seegenschmiedt H, Ruge M et al (2014) Stereotactic radiosurgery for treatment of brain metastases. a report of the DEGRO working group on stereotactic radiotherapy. Strahlenther Onkol 190(6):521–532
3. Park JH, Kim YJ, Lee JO, Lee KW, Kim JH, Bang SM et al (2012) Clinical outcomes of leptomeningeal metastasis in patients with non-small cell lung cancer in the modern chemotherapy era. Lung Cancer 76(3):387–392
4. Chowdhary S, Chamberlain M (2005) Leptomeningeal metastases: current concepts and management guidelines. J Natl Compr Canc Netw 3(5):693–703
5. Chamberlain MC, Kormanik P (1998) Carcinoma meningitis secondary to non-small cell lung cancer: combined modality therapy. Arch Neurol 55(4):506–512
6. Morris PG, Reiner AS, Szenberg OR, Clarke JL, Panageas KS, Perez HR et al (2012) Leptomeningeal metastasis from non-small cell lung cancer: survival and the impact of whole brain radiotherapy. J Thorac Oncol 7(2):382–385
7. Chamberlain MC (2010) Leptomeningeal metastasis. Curr Opin Oncol 22(6):627–635
8. Wasserstrom WR, Glass JP, Posner JB (1982) Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer 49(4):759–772
9. Groves MD (2010) New strategies in the management of leptomeningeal metastases. Arch Neurol 67(3):305–312
10. Hitchins RN, Bell DR, Woods RL, Levi JA (1987) A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis. J Clin Oncol 5(10):1655–1662
11. Grossman SA, Finkelstein DM, Ruckdeschel JC, Trump DL, Moynihan T, Ettinger DS (1993) Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group. J Clin Oncol 11(3):561–569
12. Boogerd W, vd Sande JJ, Moffie D (1988) Acute fever and delayed leukoencephalopathy following low dose intraventricular methotrexate. J Neurol Neurosurg Psychiatry 51(10):1277–1283
13. Yavuz AA, Topkan E, Onal C, Yavuz MN (2008) Prophylactic cranial irradiation in locally advanced non-small cell lung cancer: outcome of recursive partitioning analysis group 1 patients. J Exp Clin Cancer Res 27:80
14. Hermann B, Hultenschmidt B, Sautter-Bihl ML (2001) Radiotherapy of the neuroaxis for palliative treatment of leptomeningeal carcinomatosis. Strahlenther Onkol 177(4):195–199
15. Nabors LB, Portnow J, Ammirati M, Brem H, Brown P, Butowski N et al (2014) Central nervous system cancers, version 2.2014. Featured updates to the NCCN guidelines. J Natl Compr Canc Netw 12:1517–1523
16. Gwak HS, Joo J, Kim S, Yoo H, Shin SH, Han JY et al (2013) Analysis of treatment outcomes of intraventricular chemotherapy in 105 patients for leptomeningeal carcinomatosis from non-small-cell lung cancer. J Thorac Oncol 8(5):599–605
17. Lee SJ, Lee JI, Nam DH, Ahn YC, Han JH, Sun JM et al (2013) Leptomeningeal carcinomatosis in non-small-cell lung cancer patients: impact on survival and correlated prognostic factors. J Thorac Oncol 8(2):185–191
18. Welsh JW, Komaki R, Amini A, Munsell MF, Unger W, Allen PK et al (2013) Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer. J Clin Oncol 31(7):895–902
19. Grossman SA, Krabak MJ (1999) Leptomeningeal carcinomatosis. Cancer Treat Rev 25(2):103–119
20. Chamberlain MC, Kormanik PA (1997) Prognostic significance of coexistent bulky metastatic central nervous system disease in patients with leptomeningeal metastases. Arch Neurol 54(11):1364–1368
21. Palma JA, Fernandez-Torron R, Esteve-Belloch P, Fontes-Villalba A, Hernandez A, Fernandez-Hidalgo O et al (2013) Leptomeningeal carcinomatosis: prognostic value of clinical, cerebrospinal fluid, and neuroimaging features. Clin Neurol Neurosurg 115(1):19–25
22. Bruna J, Gonzalez L, Miro J, Velasco R, Gil M, Tortosa A et al (2009) Leptomeningeal carcinomatosis: prognostic implications of clinical and cerebrospinal fluid features. Cancer 115(2):381–389
23. Gani C, Muller AC, Eckert F, Schroeder C, Bender B, Pantazis G et al (2012) Outcome after whole brain radiotherapy alone in intracranial leptomeningeal carcinomatosis from solid tumors. Strahlenther Onkol 188(2):148–153
24. Waki F, Ando M, Takashima A, Yonemori K, Nokihara H, Miyake M et al (2009) Prognostic factors and clinical outcomes in patients with leptomeningeal metastasis from solid tumors. J Neurooncol 93(2):205–212
25. Gong L, Xiong M, Huang Z, Miao L, Fan Y (2015) Icotinib might be effective for the treatment of leptomeningeal carcinomatosis in non-small cell lung cancer with sensitive EGFR mutations. Lung Cancer 89(3):268–273
26. Thunnissen E et al (2015) Treatment and survival of patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastasis: a retrospective cohort analysis. Lung Cancer 89(3):255–261
27. Ahn JH, Lee SH, Kim S, Joo J, Yoo H, Lee SH et al (2012) Risk for leptomeningeal seeding after resection for brain metastases: implication of tumor location with mode of resection. J Neurosurg 116(5):984–993
28. Huang AJ, Huang KE, Page BR, Ayala-Peacock DN, Lucas JT Jr, Lesser GJ et al (2014) Risk factors for leptomeningeal carcinomatosis in patients with brain metastases who have previously undergone stereotactic radiosurgery. J Neurooncol 120(1):163–169